A Phase 3 Prospective, Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Efficacy and safety of Rebiotix RBX2660 (microbiota suspension) for the Prevention of Recurrent Clostridium difficile Infection
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Rebiotix Inc.
Start Date
June 19, 2019
End Date
November 19, 2021
Administered By
Medicine, Gastroenterology
Awarded By
Rebiotix Inc.
Start Date
June 19, 2019
End Date
November 19, 2021